• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在无外源性饲养细胞情况下,CD28共刺激对CD4 + T细胞长期增殖的影响。

Effects of CD28 costimulation on long-term proliferation of CD4+ T cells in the absence of exogenous feeder cells.

作者信息

Levine B L, Bernstein W B, Connors M, Craighead N, Lindsten T, Thompson C B, June C H

机构信息

Henry M. Jackson Foundation for the Advancement of Military Medicine, U.S. Military HIV Research Program, Bethesda, MD 20889, USA.

出版信息

J Immunol. 1997 Dec 15;159(12):5921-30.

PMID:9550389
Abstract

In this report, conditions for prolonged in vitro proliferation of polyclonal adult CD4+ T cells via stimulation with immobilized anti-CD3 plus anti-CD28 have been established. CD4+ cells maintained exponential growth for more than 60 days during which a total 10(9)- to 10(11)-fold expansion occurred. Cell cultures exhibited cyclical changes in cell volume, indicating that, in terms of proliferative rate, cells do not have to rest before restimulation. Indeed, electronic cell size analysis was the most reliable method to determine when to restimulate with additional immobilized mAb. The initial approximately 10(5)-fold expansion was autocrine, occurring in the absence of exogenous cytokines or feeder cells. Addition of recombinant human IL-2 after the initial autocrine expansion resulted in continued exponential proliferation. Phorbol ester plus ionomycin also induced long-term growth when combined with anti-CD28 stimulation. Analysis of the T cell repertoire after prolonged expansion revealed a diverse repertoire as assessed by anti-TCR Vbeta Abs or a PCR-based assay. Cytokines produced were consistent with maintenance of both Th1 and Th2 phenotypes; however, the mode of CD3 and CD28 stimulation could influence the cytokine secretion pattern. When anti-CD3 and anti-CD28 were immobilized on the same surface, ELISAs on culture supernatants revealed a pattern consistent with Th1 secretion. Northern analysis revealed that cytokine gene expression remained inducible. Spontaneous growth or cell transformation was not observed in more than 100 experiments. Together, these observations may have implications for gene therapy and adoptive immunotherapy. Furthermore, these culture conditions establish a model to study the finite lifespan of mature T lymphocytes.

摘要

在本报告中,已建立了通过固定化抗CD3加抗CD28刺激使多克隆成年CD4 + T细胞在体外长期增殖的条件。CD4 +细胞维持指数生长超过60天,在此期间总共发生了10^9至10^11倍的扩增。细胞培养物表现出细胞体积的周期性变化,这表明就增殖率而言,细胞在再次刺激前无需休息。实际上,电子细胞大小分析是确定何时用额外的固定化单克隆抗体进行再次刺激的最可靠方法。最初约10^5倍的扩增是自分泌的,在没有外源性细胞因子或饲养细胞的情况下发生。在最初的自分泌扩增后添加重组人IL-2导致持续的指数增殖。佛波酯加离子霉素与抗CD28刺激联合使用时也可诱导长期生长。长期扩增后对T细胞库的分析显示,通过抗TCR Vβ抗体或基于PCR的检测评估,其具有多样性。产生的细胞因子与Th1和Th2表型的维持一致;然而,CD3和CD28刺激的方式可能影响细胞因子分泌模式。当抗CD3和抗CD28固定在同一表面上时,对培养上清液的ELISA显示出与Th1分泌一致的模式。Northern分析显示细胞因子基因表达仍可诱导。在超过100次实验中未观察到自发生长或细胞转化。总之,这些观察结果可能对基因治疗和过继性免疫治疗有影响。此外,这些培养条件建立了一个研究成熟T淋巴细胞有限寿命的模型。

相似文献

1
Effects of CD28 costimulation on long-term proliferation of CD4+ T cells in the absence of exogenous feeder cells.在无外源性饲养细胞情况下,CD28共刺激对CD4 + T细胞长期增殖的影响。
J Immunol. 1997 Dec 15;159(12):5921-30.
2
Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.利用抗CD3/CD28、白细胞介素-7和白细胞介素-15对树突状细胞激活的抗原特异性CD4+ T细胞进行体外扩增:过继性T细胞免疫疗法的潜力
Clin Immunol. 2006 Apr;119(1):21-31. doi: 10.1016/j.clim.2005.11.003. Epub 2006 Jan 9.
3
TCR-independent activation of human CD4+ 45RO- T cells by anti-CD28 plus IL-2: Induction of clonal expansion and priming for a Th2 phenotype.抗CD28加白细胞介素-2对人CD4+ 45RO- T细胞的TCR非依赖性激活:克隆扩增的诱导及Th2表型的启动。
J Immunol. 1996 Jun 1;156(11):4100-6.
4
The CD2 and CD28 adhesion molecules induce long-term autocrine proliferation of CD4+ T cells.CD2和CD28黏附分子可诱导CD4+ T细胞长期自分泌增殖。
Eur J Immunol. 1993 Mar;23(3):608-13. doi: 10.1002/eji.1830230304.
5
CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes.CD28是一种可诱导的T细胞表面抗原,它能在CD3+成熟胸腺细胞中传导增殖信号。
J Immunol. 1990 Mar 1;144(5):1646-53.
6
A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.一种人源化治疗性CD4单克隆抗体可抑制TCR诱导的IL-2、IL-4和IL-10分泌以及CD25、CD40L和CD69的表达。
Cell Immunol. 1998 May 1;185(2):101-13. doi: 10.1006/cimm.1998.1287.
7
Phenotypic and functional modulation of interleukin-2-activated peripheral blood mononuclear cells by anti-CD3 and anti-CD28 antibody.抗CD3和抗CD28抗体对白细胞介素-2激活的外周血单个核细胞的表型和功能调节
Lymphokine Cytokine Res. 1993 Aug;12(4):191-6.
8
Antibody-induced CD3-CD4 coligation inhibits TCR/CD3 activation in the absence of costimulatory signals in normal mouse CD4(+) T lymphocytes.在正常小鼠CD4(+) T淋巴细胞中,抗体诱导的CD3-CD4共连接在缺乏共刺激信号的情况下抑制TCR/CD3激活。
Cell Immunol. 1999 Aug 1;195(2):96-109. doi: 10.1006/cimm.1999.1529.
9
Deficient CD4+ T cell proliferation in the class 1 MHC-restricted 2C TCR-transgenic mouse.在I类主要组织相容性复合体(MHC)限制的2C TCR转基因小鼠中CD4 + T细胞增殖不足。
J Immunol. 1996 Mar 15;156(6):2036-44.
10
Anti-CD28-induced co-stimulation and TCR avidity regulates the differential effect of TGF-beta1 on CD4+ and CD8+ naïve human T-cells.抗CD28诱导的共刺激和TCR亲和力调节转化生长因子-β1对CD4+和CD8+初始人T细胞的不同作用。
Int Immunol. 2005 Jan;17(1):35-44. doi: 10.1093/intimm/dxh183. Epub 2004 Nov 22.

引用本文的文献

1
Engineering mRNA CAR-T Cells for Cancer Immunotherapy.用于癌症免疫治疗的工程化信使核糖核酸嵌合抗原受体T细胞
Methods Mol Biol. 2025;2965:285-321. doi: 10.1007/978-1-0716-4742-4_14.
2
Next-generation immunotherapeutic approaches for blood cancers: Exploring the efficacy of CAR-T and cancer vaccines.血液癌症的新一代免疫治疗方法:探索嵌合抗原受体T细胞(CAR-T)和癌症疫苗的疗效。
Exp Hematol Oncol. 2025 May 17;14(1):75. doi: 10.1186/s40164-025-00662-3.
3
Ongoing Radiographic Response for Over 20 Months in Metastatic Cancer Without Continued Immune Checkpoint Inhibitor (ICI) Dosing.
转移性癌症在未持续给予免疫检查点抑制剂(ICI)的情况下持续20多个月的影像学反应。
Cureus. 2025 Mar 6;17(3):e80126. doi: 10.7759/cureus.80126. eCollection 2025 Mar.
4
Advances in CAR T cell therapy: antigen selection, modifications, and current trials for solid tumors.嵌合抗原受体T细胞疗法的进展:抗原选择、修饰及实体瘤的当前试验
Front Immunol. 2025 Jan 6;15:1489827. doi: 10.3389/fimmu.2024.1489827. eCollection 2024.
5
Artificial antigen-presenting cells: the booster for the obtaining of functional adoptive cells.人工抗原呈递细胞:获得功能性过继细胞的助推器。
Cell Mol Life Sci. 2024 Aug 31;81(1):378. doi: 10.1007/s00018-024-05412-y.
6
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers.靶向 TRBC1 的抗体药物偶联物用于治疗 T 细胞癌症。
Nature. 2024 Apr;628(8007):416-423. doi: 10.1038/s41586-024-07233-2. Epub 2024 Mar 27.
7
Nanofibrous MultiDomain Peptide Hydrogels Provide T Cells a 3D, Cytocompatible Environment for Cell Expansion and Antigen-Specific Killing.纳米纤维多结构域肽水凝胶为 T 细胞提供三维、细胞相容的环境,用于细胞扩增和抗原特异性杀伤。
ACS Biomater Sci Eng. 2024 Mar 11;10(3):1448-1460. doi: 10.1021/acsbiomaterials.3c01617. Epub 2024 Feb 22.
8
PGE2-EP2/EP4 signaling elicits mesoCAR T cell immunosuppression in pancreatic cancer.PGE2-EP2/EP4 信号在胰腺癌中诱导间充质 CAR T 细胞免疫抑制。
Front Immunol. 2023 Jun 30;14:1209572. doi: 10.3389/fimmu.2023.1209572. eCollection 2023.
9
Augmenting TCR signal strength and ICOS costimulation results in metabolically fit and therapeutically potent human CAR Th17 cells.增强 TCR 信号强度和 ICOS 共刺激可产生代谢健康且治疗有效的人源性 CAR Th17 细胞。
Mol Ther. 2023 Jul 5;31(7):2120-2131. doi: 10.1016/j.ymthe.2023.04.010. Epub 2023 Apr 20.
10
Shape matters: Biodegradable anisotropic nanoparticle artificial antigen presenting cells for cancer immunotherapy.形状很重要:用于癌症免疫治疗的可生物降解各向异性纳米颗粒人工抗原呈递细胞。
Acta Biomater. 2023 Apr 1;160:187-197. doi: 10.1016/j.actbio.2023.02.023. Epub 2023 Feb 21.